ULTRASOUND CONTRAST AGENT SONAZOID

Summary

Hepatic epithelioid angiomyolipoma (HEAML) is a rare variant of angiomyolipoma that occurs in the liver and mimics hepatocellular carcinoma on imaging. This case report describes the use of contrast-enhanced ultrasonography (CEUS) with the contrast agent Sonazoid® to differentiate HEAML from hepatocellular carcinoma.

The study demonstrates the potential of CEUS with Sonazoid® for accurate diagnosis and characterization of HEAML, providing valuable guidance for clinicians and radiologists.

Contact Support

If you're interested in posting an article and need assistance, please don't hesitate to contact our support team. We're here to help you through the process, answer any questions you may have, and ensure that your article is published smoothly and effectively.

support@ehealthcommunity.org